Literature DB >> 18444083

Furious and paralytic rabies of canine origin: neuroimaging with virological and cytokine studies.

Jiraporn Laothamatas1, Supaporn Wacharapluesadee, Boonlert Lumlertdacha, Sumate Ampawong, Vera Tepsumethanon, Shanop Shuangshoti, Patta Phumesin, Sawwanee Asavaphatiboon, Ladawan Worapruekjaru, Yingyos Avihingsanon, Nipan Israsena, Monique Lafon, Henry Wilde, Thiravat Hemachudha.   

Abstract

Furious and paralytic rabies differ in clinical manifestations and survival periods. The authors studied magnetic resonance imaging (MRI) and cytokine and virus distribution in rabies-infected dogs of both clinical types. MRI examination of the brain and upper spinal cord was performed in two furious and two paralytic dogs during the early clinical stage. Rabies viral nucleoprotein RNA and 18 cytokine mRNAs at 12 different brain regions were studied. Rabies viral RNA was examined in four furious and four paralytic dogs during the early stage, and in one each during the late stage. Cytokine mRNAs were examined in two furious and two paralytic dogs during the early stage and in one each during the late stage. Larger quantities of rabies viral RNA were found in the brains of furious than in paralytic dogs. Interleukin-1beta and interferon-gamma mRNAs were found exclusively in the brains of paralytic dogs during the early stage. Abnormal hypersignal T2 changes were found at hippocampus, hypothalamus, brainstem, and spinal cord of paralytic dogs. More widespread changes of less intensity were seen in furious dog brains. During the late stage of infection, brains from furious and paralytic rabid dogs were similarly infected and there were less detectable cytokine mRNAs. These results suggest that the early stage of furious dog rabies is characterized by a moderate inflammation (as indicated by MRI lesions and brain cytokine detection) and a severe virus neuroinvasiveness. Paralytic rabies is characterized by delayed viral neuroinvasion and a more intense inflammation than furious rabies. Dogs may be a good model for study of the host inflammatory responses that may modulate rabies virus neuroinvasiveness.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18444083     DOI: 10.1080/13550280701883857

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  31 in total

1.  Failure to open the blood-brain barrier and deliver immune effectors to central nervous system tissues leads to the lethal outcome of silver-haired bat rabies virus infection.

Authors:  Anirban Roy; Timothy W Phares; Hilary Koprowski; D Craig Hooper
Journal:  J Virol       Date:  2006-11-15       Impact factor: 5.103

2.  Induction of immunoreactive interleukin-1 beta and tumor necrosis factor-alpha in the brains of rabies virus infected rats.

Authors:  C Marquette; A M Van Dam; P E Ceccaldi; P Weber; F Haour; H Tsiang
Journal:  J Neuroimmunol       Date:  1996-08       Impact factor: 3.478

3.  Up-regulation of Fas ligand (FasL) in the central nervous system: a mechanism of immune evasion by rabies virus.

Authors:  Leïla Baloul; Serge Camelo; Monique Lafon
Journal:  J Neurovirol       Date:  2004-12       Impact factor: 2.643

Review 4.  Human rabies: a disease of complex neuropathogenetic mechanisms and diagnostic challenges.

Authors:  Thiravat Hemachudha; Jiraporn Laothamatas; Charles E Rupprecht
Journal:  Lancet Neurol       Date:  2002-06       Impact factor: 44.182

Review 5.  Subversive neuroinvasive strategy of rabies virus.

Authors:  M Lafon
Journal:  Arch Virol Suppl       Date:  2004

6.  Regional distribution of rabies viral antigen in central nervous system of human encephalitic and paralytic rabies.

Authors:  S Tirawatnpong; T Hemachudha; S Manutsathit; S Shuangshoti; K Phanthumchinda; P Phanuphak
Journal:  J Neurol Sci       Date:  1989-08       Impact factor: 3.181

7.  Immunologic study of human encephalitic and paralytic rabies. Preliminary report of 16 patients.

Authors:  T Hemachudha; P Phanuphak; B Sriwanthana; S Manutsathit; K Phanthumchinda; W Siriprasomsup; C Ukachoke; S Rasameechan; S Kaoroptham
Journal:  Am J Med       Date:  1988-04       Impact factor: 4.965

8.  Mechanisms of escape phenomenon of spinal cord and brainstem in human rabies.

Authors:  Sasiwimol Juntrakul; Preecha Ruangvejvorachai; Shanop Shuangshoti; Supaporn Wacharapluesadee; Thiravat Hemachudha
Journal:  BMC Infect Dis       Date:  2005-11-16       Impact factor: 3.090

9.  Transmission dynamics of rabies virus in Thailand: implications for disease control.

Authors:  Jessada Denduangboripant; Supaporn Wacharapluesadee; Boonlert Lumlertdacha; Nipada Ruankaew; Wirongrong Hoonsuwan; Apirom Puanghat; Thiravat Hemachudha
Journal:  BMC Infect Dis       Date:  2005-06-29       Impact factor: 3.090

10.  Survey for bat lyssaviruses, Thailand.

Authors:  Boonlert Lumlertdacha; Kalyanee Boongird; Sawai Wanghongsa; Supaporn Wacharapluesadee; Lawan Chanhome; Pkamatz Khawplod; Thiravat Hemachudha; Ivan Kuzmin; Charles E Rupprecht
Journal:  Emerg Infect Dis       Date:  2005-02       Impact factor: 6.883

View more
  14 in total

1.  Virology, immunology and pathology of human rabies during treatment.

Authors:  Yolanda Caicedo; Andres Paez; Ivan Kuzmin; Michael Niezgoda; Lillian A Orciari; Pamela A Yager; Sergio Recuenco; Richard Franka; Andres Velasco-Villa; Rodney E Willoughby
Journal:  Pediatr Infect Dis J       Date:  2015-05       Impact factor: 2.129

2.  The type I interferon response bridles rabies virus infection and reduces pathogenicity.

Authors:  Damien Chopy; Claudia N Detje; Mireille Lafage; Ulrich Kalinke; Monique Lafon
Journal:  J Neurovirol       Date:  2011-07-30       Impact factor: 2.643

3.  Therapeutic immune clearance of rabies virus from the CNS.

Authors:  D Craig Hooper; Anirban Roy; Rhonda B Kean; Timothy W Phares; Darryll A Barkhouse
Journal:  Future Virol       Date:  2011-03-01       Impact factor: 1.831

4.  Inhibition of MALT1 Decreases Neuroinflammation and Pathogenicity of Virulent Rabies Virus in Mice.

Authors:  S Van Gucht; R Beyaert; E Kip; J Staal; H G Tima; L Verstrepen; M Romano; K Lemeire; V Suin; A Hamouda; M Baens; C Libert; M Kalai
Journal:  J Virol       Date:  2018-10-29       Impact factor: 5.103

5.  Atypical rabies with MRI findings: clue to the diagnosis.

Authors:  Arvind Kumar Vaish; Nirdesh Jain; Lokesh Kumar Gupta; Sudhir Kumar Verma
Journal:  BMJ Case Rep       Date:  2011-06-29

6.  Rabies virus is recognized by the NLRP3 inflammasome and activates interleukin-1β release in murine dendritic cells.

Authors:  Tessa M Lawrence; Andrew W Hudacek; Marcel R de Zoete; Richard A Flavell; Matthias J Schnell
Journal:  J Virol       Date:  2013-03-13       Impact factor: 5.103

7.  Reduced viral burden in paralytic compared to furious canine rabies is associated with prominent inflammation at the brainstem level.

Authors:  Shanop Shuangshoti; Nischol Thepa; Pornchai Phukpattaranont; Akanitt Jittmittraphap; Nirun Intarut; Veera Tepsumethanon; Supaporn Wacharapluesadee; Paul Scott Thorner; Thiravat Hemachudha
Journal:  BMC Vet Res       Date:  2013-02-14       Impact factor: 2.741

8.  International Veterinary Epilepsy Task Force recommendations for a veterinary epilepsy-specific MRI protocol.

Authors:  Clare Rusbridge; Sam Long; Jelena Jovanovik; Marjorie Milne; Mette Berendt; Sofie F M Bhatti; Luisa De Risio; Robyn G Farqhuar; Andrea Fischer; Kaspar Matiasek; Karen Muñana; Edward E Patterson; Akos Pakozdy; Jacques Penderis; Simon Platt; Michael Podell; Heidrun Potschka; Veronika M Stein; Andrea Tipold; Holger A Volk
Journal:  BMC Vet Res       Date:  2015-08-28       Impact factor: 2.741

9.  Street rabies virus causes dendritic injury and F-actin depolymerization in the hippocampus.

Authors:  Yan Song; Jinli Hou; Bin Qiao; Yanchao Li; Ye Xu; Ming Duan; Zhenhong Guan; Maolin Zhang; Liankun Sun
Journal:  J Gen Virol       Date:  2012-10-31       Impact factor: 3.891

10.  Intracellular Spread of Rabies Virus Is Reduced in the Paralytic Form of Canine Rabies Compared to the Furious Form.

Authors:  Shanop Shuangshoti; Paul Scott Thorner; Chinachote Teerapakpinyo; Nisachol Thepa; Pornchai Phukpattaranont; Nirun Intarut; Boonlert Lumlertdacha; Veera Tepsumethanon; Thiravat Hemachudha
Journal:  PLoS Negl Trop Dis       Date:  2016-06-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.